Bortezomib Onko (Bortezomib), 3.5 mg, Powder for solution for Injection-Vial
Product Description
Onko Ilac Sanayi ve Ticaret A.S.
-
TR
-
2015On CPHI since
-
3Certificates
-
500 - 999Employees
Company types
Primary activities
Categories
Onko Ilac Sanayi ve Ticaret A.S.
-
TR
-
2015On CPHI since
-
3Certificates
-
500 - 999Employees
Company types
Primary activities
More Products from Onko Ilac Sanayi ve Ticaret A.S. (35)
-
Product Mycophenolate Mofetil 250mg-500mg
Mycophenolate Mofetil is an immunosuppressant medication used to prevent rejection following organ transplantation and to treat autoimmune conditions such as Crohn's disease and lupus. -
Product Oxatu-S (Oxaliplatin) 50MG/10ML - 100 MG/20 ML
Oxaliplatin is a cancer medication used to treat colorectal cancer. Often it is used together with fluorouracil and folinic acid in advanced cancer. It is given by injection into a vein -
Product Pamintu 10mg/10ml (Protamine Sulphate)
Protamine sulfate is a medication that is used to reverse the effects of heparin. It is specifically used in heparin overdose, in low molecular weight heparin overdose, and to reverse the effects of heparin during delivery and heart surgery. It is given by injection into a vein. -
Product Pemetu (Pemetreksed disodium) 500 mg/20ml - 100 mg/4ml
Pemetreksed is a chemotherapy medication for the treatment of pleural mesothelioma and non-small cell lung cancer. -
Product Temozolomide 5mg-20mg-100mg-250mg
Temozolomide is a medication used to treat some brain tumors such as glioblastoma multiforme or anaplastic astrocytoma -
Product Zomtu (Zoledronic Acid) Concentrated Solution for IV Infusion - Vial, 4 mg/5 ml, 4 mg/100 ml
Zomtu (Zoledronic Acid) Concentrated Solution for IV Infusion - Vial, 4 mg/5 ml, 4 mg/100 ml is used along with cancer chemotherapy to treat bone damage caused by multiple myeloma or by cancer that began in another part of the body but has spread to the bones. Please contact us for more information. -
Product Azatu (Azacitidine), 100 mg, Powder for Injection Suspension-Vial
Azacitidine,100 mg, Powder for Injection Suspension- Vial is used to treat acute myelogenous leukemia, chronic myelogenous leukemia (CML), myelodysplastic syndrome. Contact us for more information. -
Product Zomtu (Zoledronic Acid) Concentrated Solution for IV Infusion - Vial, 4 mg/5 ml, 4 mg/100 ml
Zomtu (Zoledronic Acid) Concentrated Solution for IV Infusion - Vial, 4 mg/5 ml, 4 mg/100 ml is used along with cancer chemotherapy to treat bone damage caused by multiple myeloma or by cancer that began in another part of the body but has spread to the bones. Please contact us for more information.
... -
Product Kopaq (Iohexol), Concentrated Solution for Injection - Vial, 300 mgI/ml (50 ml), 300 mgI/ml (100 ml), 350 mgl/ml (50 ml), 350 mgl/ml (100 ml), 350 mgl/ml (200 ml)
Kopaq (Iohexol), Concentrated Solution for Injection - Vial, 300 mgI/ml (50 ml), 300 mgI/ml (100 ml), 350 mgl/ml (50 ml), 350 mgl/ml (100 ml), 350 mgl/ml (200 ml) is a iodinated, nonionic, low osmolar contrast agent.The product is used in arthrography, endoscopic retrograde pancreatography (ERP), endoscopi... -
Product Misintu (Mitomycin), 20 mg, Powder for Solution for Injection/Infusion
Misintu (Mitomycin), 20 mg, Powder for Solution for Injection/Infusion is used to treat bladder cancer, breast cancer, head and neck cancer, stomach and pancreatic cancer, prostate cancer and cervical cancer. Contact us for more information. -
Product Docetu (Docetaxel) 20 mg/ml, 80 mg/ml, 160 mg/8 ml
Docetaxel is an antineoplastic agent. It is prepared by semisynthesis beginning with a precursor extracted from the renewable needle biomass of yew plants. Docetaxel is a white to almost-white powder with an empirical formula of C43H53NO14• 3H2O, and a molecular weight of 861.9. It... -
Product Epiritu (Epirubicine HCL) 10 mg/5 ml, 200 mg/100 ml, 50 mg/25 ml
Epiritu is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. This medication is classified as an "anthracyline antitumor antibiotic. Epiritu is used to treat breast cancer. It is used as adjuvant therapy in women who have had surgery and have lymph node involvement.May be...
Onko Ilac Sanayi ve Ticaret A.S. resources (2)
-
News Bortezomib Injection 3.5 mg vial DCP application
Onko Koçsel is proud that Bortezomib Injection 3.5 mg vial DCP application has been successfully accepted by EMA member countries on March, 2021. Onko Koçsel is open for collaboration within and outside EU countries.
-
Video Onko Kocsel Factory video
Onko Kocsel Factory video
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance